… We selected relevant randomized clinical studies discussing NAC in patients with OCD. We
selected eligible studies, independently extracted the data, individually evaluated the quality …

… tolerability as well as its good safety profile and lack of significant interaction with standard
OCD medications further highlight its potential benefits as add-on therapy for refractory OCD. …

Objective: To evaluate the efficacy of serotonin reuptake inhibitor (SRI) augmentation with N-acetylcysteine
(NAC), a glutamate modulator and antioxidant medication, for treatment-…

… Treatment resistance is a barrier to the successful care of patients with OCD. Glutamate
modulators such as n-acetylcysteine (NAC) represent a promising new treatment option. To …

… Preliminary evidence has suggested that adjunctive N-acetylcysteine (NAC), an antioxidant
… of obsessive-compulsive disorder (OCD). We conducted a 20-week, multi-site, randomized …

… NAC add-on therapy might be a potential pharmacological approach to treatment-resistant …
age of 31 years, were randomized into two equal groups and treated with SSRIs, at the same …

… , only a handful of which may have been randomized into the current study. Furthermore, the
form … N-acetylcysteine augmentation in treatment resistant obsessive compulsive disorder: A …

… Ghanizadeh et al 17 conducted a 10-week, randomized, double-blind, placebo-controlled,
multi-center clinical trial analyzing the effect of NAC as add-on therapy to SSRI therapy in 34 …

… Our findings stand in contrast to studies suggesting benefits of NAC in the treatment of other
obsessive-compulsive spectrum disorders in adults, including OCD and trichotillomania, but …

… Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF: N-Acetylcysteine in the treatment
of pediatric trichotillomania: A randomized, double-blind, placebo-controlled add-on trial. J …